ENDP Stock - Endo International plc
Unlock GoAI Insights for ENDP
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|
| Revenue | $2.99B | $2.90B | $2.91B | $2.95B | $3.47B |
| Gross Profit | $1.77B | $1.46B | $1.35B | $1.32B | $1.24B |
| Gross Margin | 59.2% | 50.3% | 46.2% | 44.6% | 35.8% |
| Operating Income | $15.75M | $603.15M | $581.87M | $-469,129,000 | $-960,065,000 |
| Net Income | $-569,081,000 | $183.94M | $-422,636,000 | $-1,031,469,000 | $-2,035,433,000 |
| Net Margin | -19.0% | 6.3% | -14.5% | -35.0% | -58.7% |
| EPS | $-2.44 | $0.79 | $-1.87 | $-4.61 | $-9.12 |
Endo International plc, a specialty pharmaceutical company, manufactures and sells generic and branded pharmaceuticals in the United States and internationally. Its Branded Pharmaceuticals segment provides branded prescription products, including XIAFLEX to treat adult patients with Dupuytren's contracture; SUPPRELIN LA to treat central precocious puberty in children; NASCOBAL nasal spray to treat vitamin B12 deficiency; AVEED to treat hypogonadism; QWO, an injectable treatment for moderate to severe cellulite in the buttocks of adult women; PERCOCET to treat moderate-to-moderately-severe pain; TESTOPEL an implantable pellet indicated for TRT in conditions associated with a deficiency or absence of endogenous testosterone; EDEX to treat erectile dysfunction; LIDODERM a topical patch product containing lidocaine for the relief of pain; and products for the pain management and urology. The company's Sterile Injectables segment manufactures VASOSTRICT, a vasopressin injection; ADRENALIN, a non-selective adrenergic agonist; and APLISOL, which is a sterile aqueous solution, as well as generic sterile injectable products, including ertapenem for injections and ephedrine sulfate injections. Its Generic Pharmaceuticals segment offers solid oral extended-release, solid oral immediate-release, liquids, semi-solids, patches, powders, ophthalmic products, and sprays. The company's International Pharmaceuticals segment offers specialty pharmaceutical products in various therapeutic areas comprising attention deficit hyperactivity disorder, pain, women's health, oncology, and transplantation. The company sells its branded pharmaceuticals and generics to specialty physicians, retailers, clinics, government agencies, doctors, retail and specialty pharmacies, and specialty distributors. Endo International plc was founded in 1920 and is headquartered in Dublin, Ireland. On August 16, 2022, Endo International plc, along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of New York.
Visit WebsiteRating Distribution
Price Targets
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| May 6th 2022 | Piper Sandler | Downgrade | Underweight | $1← $3 |
Earnings History & Surprises
ENDPEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2022 | Aug 9, 2022 | $-0.14 | $0.03 | +121.4% | ✓ BEAT |
Q2 2022 | May 5, 2022 | $0.44 | $0.66 | +50.0% | ✓ BEAT |
Q1 2022 | Feb 28, 2022 | $0.67 | $0.84 | +25.4% | ✓ BEAT |
Q4 2021 | Nov 4, 2021 | $0.48 | $0.80 | +66.7% | ✓ BEAT |
Q3 2021 | Aug 5, 2021 | $0.48 | $0.65 | +35.4% | ✓ BEAT |
Q2 2021 | May 6, 2021 | $0.48 | $0.73 | +52.1% | ✓ BEAT |
Q1 2021 | Feb 25, 2021 | $0.48 | $0.75 | +56.3% | ✓ BEAT |
Q4 2020 | Nov 5, 2020 | $0.14 | $0.52 | +271.4% | ✓ BEAT |
Q3 2020 | Aug 5, 2020 | $0.34 | $0.65 | +91.2% | ✓ BEAT |
Q2 2020 | May 7, 2020 | $0.55 | $0.95 | +72.7% | ✓ BEAT |
Q1 2020 | Feb 26, 2020 | $0.57 | $0.74 | +29.8% | ✓ BEAT |
Q4 2019 | Nov 4, 2019 | $0.53 | $0.60 | +13.2% | ✓ BEAT |
Q3 2019 | Aug 5, 2019 | $0.48 | $0.52 | +8.3% | ✓ BEAT |
Q2 2019 | May 9, 2019 | $0.43 | $0.53 | +23.3% | ✓ BEAT |
Q1 2019 | Feb 28, 2019 | $0.59 | $0.75 | +27.1% | ✓ BEAT |
Q4 2018 | Nov 8, 2018 | $0.59 | $0.71 | +20.3% | ✓ BEAT |
Q3 2018 | Aug 8, 2018 | $0.54 | $0.76 | +40.7% | ✓ BEAT |
Q2 2018 | May 8, 2018 | $0.55 | $0.67 | +21.8% | ✓ BEAT |
Q1 2018 | Feb 27, 2018 | $0.61 | $0.77 | +26.2% | ✓ BEAT |
Q4 2017 | Nov 9, 2017 | $0.71 | $0.91 | +28.2% | ✓ BEAT |
Latest News
Frequently Asked Questions about ENDP
What is ENDP's current stock price?
What is the analyst price target for ENDP?
What sector is Endo International plc in?
What is ENDP's market cap?
Does ENDP pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to ENDP for comparison